Linkwell Corporation Announces Receipt of Business Plan from Wharton-Fudan Universities
Linkwell Corporation Announces Receipt of Business Plan from Wharton-Fudan
Universities
SHANGHAI, China, May 21 /Xinhua-PRNewswire-FirstCall/ -- Linkwell
Corporation (Linkwell or the Company) (OTC Bulletin Board: LWLL), a leading
developer, manufacturer and distributor of healthcare related disinfectants in
China, announced today they were in receipt of a detailed comprehensive
business plan from Wharton and Fudan Universities as a result of the Wharton
Global Consulting Practicum (GCP) program. The program concluded with a two
day colloquium on May 13th and 14th at Wharton College and the University of
Pennsylvania in Philadelphia.
"We are very appreciative of everyone involved in the GCP program,"
commented Linkwell Chairman and CEO, Mr. Xuelian Bian. "The process and
products will help us to reach the next two levels in our business
development." The program's objectives were to bring new strategic thinking
and ideas to Linkwell; discuss growth plan details, action steps, and share
critical factors for driving growth; discuss the business plan; engage
industry experts on relevant topics for insights; and provide written
materials to the Company, including a business plan, to accomplish these
objectives.
During the GCP program which lasted six months, participants evaluated 5
disinfectant markets for size, growth trends, risks and barriers to entry.
Then they developed a deep analysis of the market environment for the medical
sector, with special focus on customers; competitors; distribution network
analysis; and growth strategy initiatives. The program concluded with the
writing and presentation of a customized business plan containing financial
projections; a funding plan; an implementation plan for growth initiatives,
including sales effectiveness, pricing, marketing, innovations, acquisitions
and pharmacy market sizing.
The GCP report stated, "Already exceeding RMB 6.5B (US$ 928M), China's
medical disinfectant market is expected to grow steadily at 15% over the next
five years. Beyond medical disinfectants, opportunities abound in China's
nascent home-use disinfectants market (approximately RMB 14B/US$ 2B and
growing at 13% per year) and the market for commercial-use disinfectants
(approximately RMB 4B/US$ 571M and growing at 15% per year)". GCP recommended
Linkwell Corporation focus on medical disinfectants at the present time, then
go into home-use disinfectants market in the near future.
"The preparation and research was detailed, academically rigorous,
practical," commented Linkwell COO, Mr. Arthur Huang. "The planning is
pragmatic, creative, innovative, flexible; I believe we can integrate their
four stage business strategy with the one we had created."
The plan and other products provide Linkwell with deep market analysis,
including opportunities and risks and a thorough corporate analysis of
Linkwell and the competition's strengths and weaknesses. In the colloquium,
Linkwell's management team dialogued with many industry experts, including
sales, marketing and law experts. Many of these experts serve on the GCP
board of directors with many years of experience in their fields, and shared
their real-life advice and experience to Linkwell.
Mr. Bian concluded, "We highly value the Wharton GCP four stage business
strategy and support products. Everyone has lived up to Wharton and Fudan's
esteemed reputation and their work was truly impressive and greatly
appreciated. In fact, we believe that this information is so powerful that we
plan to use it for years to come to help us grow into a large and successful
company."
About Linkwell Corporation
Linkwell develops, manufactures and distributes disinfectant healthcare
products in China through its subsidiary LiKang Disinfectant. Linkwell's
disinfectant healthcare products are a nationally recognized domestic Chinese
brand in this market segment. Linkwell products include disinfectants in
liquid, tablet, powder and aerosol form. Through LiKang, Linkwell has a
national marketing and sales presence throughout all 22 provinces, 5
autonomous regions, and 4 special municipalities of China.
For more information, please visit http://www.linkwell.us .
Safe Harbor Statement
This news release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. These
forward-looking statements are based on current expectations or beliefs,
including, but not limited to, statements concerning the Company's operations,
financial performance and condition. For this purpose, statements that are not
statements of historical fact may be deemed to be forward-looking statements.
The Company cautions that these statements by their nature involve risks and
uncertainties, and actual results may differ materially depending on a variety
of important factors, including, but not limited to, the impact of competitive
products; pricing and new technology; changes in consumer preferences and
tastes; effectiveness of marketing; changes in laws and regulations;
fluctuations in costs of production; and other factors as those discussed in
the Company's reports filed with the Securities and Exchange Commission from
time to time. In addition, the Company disclaims any obligation to update any
forward-looking statements to reflect events or circumstances after the date
hereof.
For more information, please contact:
Investor Relations
Craig Bird
Segue Ventures LLC
Tel: +1-215-885-4981
Email: chbird@segue.biz
SOURCE Linkwell Corporation
Investor Relations, Craig Bird, Segue Ventures LLC, +1-215-885- 4981, or
chbird@segue.biz
© Thomson Reuters 2009 All rights reserved




